Found: 26
Select item for more details and to access through your institution.
GDNF/GFRA1 signaling contributes to chemo- and radioresistance in glioblastoma.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-68626-x
- By:
- Publication type:
- Article
Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Extracranial metastases in glioblastoma—Two case stories.
- Published in:
- Clinical Case Reports, 2019, v. 7, n. 2, p. 289, doi. 10.1002/ccr3.1980
- By:
- Publication type:
- Article
Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Differential expression of checkpoint markers in the normoxic and hypoxic microenvironment of glioblastomas.
- Published in:
- Brain Pathology, 2023, v. 33, n. 1, p. 1, doi. 10.1111/bpa.13111
- By:
- Publication type:
- Article
Surgical resection of glioblastomas induces pleiotrophin-mediated self-renewal of glioblastoma stem cells in recurrent tumors.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 7, p. 1074, doi. 10.1093/neuonc/noab302
- By:
- Publication type:
- Article
PATH-21. ANGIOTENSINOGEN GENE SILENCING PREDICTS BEVACIZUMAB RESPONSE IN RECURRENT GLIOBLASTOMA PATIENTS.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi162, doi. 10.1093/neuonc/noy148.677
- By:
- Publication type:
- Article
VEGF-C sustains VEGFR2 activation under bevacizumab therapy and promotes glioblastoma maintenance.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 11, p. 1462, doi. 10.1093/neuonc/noy103
- By:
- Publication type:
- Article
Inhibition of histone deacetylases sensitizes glioblastoma cells to lomustine.
- Published in:
- Cellular Oncology (2211-3428), 2017, v. 40, n. 1, p. 21, doi. 10.1007/s13402-016-0301-9
- By:
- Publication type:
- Article
Combined EGFR- and notch inhibition display additive inhibitory effect on glioblastoma cell viability and glioblastoma-induced endothelial cell sprouting in vitro.
- Published in:
- Cancer Cell International, 2016, v. 16, p. 1
- By:
- Publication type:
- Article
Single agent- and combination treatment with two targeted suicide gene therapy systems is effective in chemoresistant small cell lung cancer cells.
- Published in:
- Journal of Gene Medicine, 2012, v. 14, n. 7, p. 445, doi. 10.1002/jgm.2630
- By:
- Publication type:
- Article
<sup>18</sup>F-FET MicroPET and MicroMRI for Anti-VEGF and Anti-PlGF Response Assessment in an Orthotopic Murine Model of Human Glioblastoma.
- Published in:
- PLoS ONE, 2015, v. 10, n. 2, p. 1, doi. 10.1371/journal.pone.0115315
- By:
- Publication type:
- Article
The Use of Longitudinal <sup>18</sup>F-FET MicroPET Imaging to Evaluate Response to Irinotecan in Orthotopic Human Glioblastoma Multiforme Xenografts.
- Published in:
- PLoS ONE, 2014, v. 9, n. 6, p. 1, doi. 10.1371/journal.pone.0100009
- By:
- Publication type:
- Article
Molecular profiling of short-term and long-term surviving patients identifies CD34 mRNA level as prognostic for glioblastoma survival.
- Published in:
- Journal of Neuro-Oncology, 2018, v. 137, n. 3, p. 533, doi. 10.1007/s11060-017-2739-7
- By:
- Publication type:
- Article
A Prognostic Model for Glioblastoma Patients Treated With Standard Therapy Based on a Prospective Cohort of Consecutive Non-Selected Patients From a Single Institution.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.597587
- By:
- Publication type:
- Article
Development and validation of a prognostic model for recurrent glioblastoma patients treated with bevacizumab and irinotecan.
- Published in:
- Acta Oncologica, 2016, v. 55, n. 4, p. 418, doi. 10.3109/0284186X.2015.1114679
- By:
- Publication type:
- Article
The impact of bevacizumab treatment on survival and quality of life in newly diagnosed glioblastoma patients.
- Published in:
- Cancer Management & Research, 2014, v. 6, p. 373, doi. 10.2147/CMAR.S39306
- By:
- Publication type:
- Article
Genomic profiling of newly diagnosed glioblastoma patients and its potential for clinical utility – a prospective, translational study.
- Published in:
- Molecular Oncology, 2020, v. 14, n. 11, p. 2727, doi. 10.1002/1878-0261.12790
- By:
- Publication type:
- Article
Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma.
- Published in:
- Molecular Oncology, 2020, v. 14, n. 5, p. 964, doi. 10.1002/1878-0261.12660
- By:
- Publication type:
- Article
Targeting glioma stem‐like cell survival and chemoresistance through inhibition of lysine‐specific histone demethylase KDM2B.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 3, p. 406, doi. 10.1002/1878-0261.12174
- By:
- Publication type:
- Article
Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients.
- Published in:
- Molecular Oncology, 2016, v. 10, n. 8, p. 1160, doi. 10.1016/j.molonc.2016.05.005
- By:
- Publication type:
- Article
Clinical Characteristics of Gliosarcoma and Outcomes From Standardized Treatment Relative to Conventional Glioblastoma.
- Published in:
- Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01425
- By:
- Publication type:
- Article
Glioblastoma cells increase expression of notch signaling and synaptic genes within infiltrated brain tissue.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-52167-y
- By:
- Publication type:
- Article
DNA Methylation Levels of the ELMO Gene Promoter CpG Islands in Human Glioblastomas.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 3, p. 679, doi. 10.3390/ijms19030679
- By:
- Publication type:
- Article
Loss of cancer cell‐derived ADAM15 alters the tumor microenvironment in colorectal tumors.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 12, p. 2068, doi. 10.1002/ijc.34695
- By:
- Publication type:
- Article
Urokinase-Type Plasminogen Activator Receptor as a Potential PET Biomarker in Glioblastoma.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 2, p. 272, doi. 10.2967/jnumed.115.161703
- By:
- Publication type:
- Article